The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp1289
OPTIMIZING PATIENT OUTCOMES IN GERD WITH TIF 2.0
Date
May 8, 2023
Society: DDW
The TIF 2.0® procedure using the EsophyX® device provides a durable solution for GERD with fewer side effects than traditional surgery. In this session, expert panelists will discuss the importance of patient work-up and identification, review the components of the optimal antireflux barrier, and expand on emerging clinical data.
Sponsored by EndoGastric Solutions
Non-variceal upper gastrointestinal bleeding (NVUGIB) accounts for a significant number of patient visits to emergency rooms and remains a major cause of mortality and morbidity worldwide. The re-bleeding rates of NVUGIB after endoscopic treatment within 72 hours have been reported to be up to 25%…